NCT06728709 Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients
| NCT ID | NCT06728709 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Obstetric Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-12-15 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 64 participants in total. It began in 2024-12-15 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary dysfunction aggravates the illness of critically ill obstetrics and gynecological patients. Early identification with bedside technique and prompt management may improve the outcome of critical care in this vulnerable population
Eligibility Criteria
Inclusion Criteria: * Any patient admitted to the obstetrics and gynecology intensive care unit Exclusion Criteria: * Patient's refusal * inability to do a lung ultrasound examination during the first 24 hours of admission
Contact & Investigator
wessam selima, MD
PRINCIPAL INVESTIGATOR
Ain Shams University
Frequently Asked Questions
Who can join the NCT06728709 clinical trial?
This trial is open to female participants only, studying Obstetric Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06728709 currently recruiting?
Yes, NCT06728709 is actively recruiting participants. Contact the research team at w.z.selima@gmail.com for enrollment information.
Where is the NCT06728709 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06728709 clinical trial?
NCT06728709 is sponsored by Ain Shams University. The principal investigator is wessam selima, MD at Ain Shams University. The trial plans to enroll 64 participants.